form-bio
(3)
Kent Wakeford and the business of the next move
From advertising exchanges to mobile games, esports and Form Bio, Kent Wakeford has made a career of helping new industries get organized. His story follows the work behind the spectacle: partnerships, teams, measurement and software.
Andrew Busey Keeps Finding the Missing Layer
From Mosaic and web chat to social games and computational biology, Andrew Busey has spent three decades asking an unfashionably useful question: what essential piece is everyone else overlooking?
Form Bio
Form Bio is an Austin-based computational life sciences company that builds AI-driven software to speed up the design, characterization, and manufacturing of genetic medicines, especially adeno-associated virus (AAV) cell and gene therapies. Spun out of Colossal Biosciences in 2022 with a $30M Series A, its platform lets scientists model billions of therapeutic vector designs in silico to improve efficacy, safety, and manufacturability before ever entering the lab, targeting the manufacturing bottleneck that drives the majority of FDA rejections in the field.